2016 American Transplant Congress
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.
Background: Regimens with de novo everolimus (EVR) are associated with a concentration-dependent incidence of wound healing adverse events (WHAE), but mycophenolate use also is related…2016 American Transplant Congress
Factors Affecting Mortality During Waiting Time for Kidney Transplantation: A Nationwide Population-Based Cohort Study Using the Korean Network for Organ Sharing (KONOS) Database.
Background: Longer waiting times for kidney transplant have been suggested to be more deleterious than shorter waiting times. We analyzed the impact of waiting time…2016 American Transplant Congress
Influence of Country-Associated Geographical Variables in the Ouctomes of Kidney Transplantation in Patients with HIV-Infection.
Objective: To evaluate effects of geographical factors on demography, clinical management and evolution of two cohorts of HIV-infected KT recipients.Methods: Observational, retrospective cohort study including…2016 American Transplant Congress
Outcomes of Second Kidney Transplantation Compared Primary Transplantation According to Donor Specific Antibody.
Background:Re-transplantation is associated with an improved overall survival of patients with a failed renal allograft. Some studies showed the outcomes of retransplantation are than those…2016 American Transplant Congress
Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.
Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to donor-specific tolerance. Patients reported in the literature that underwent kidney transplantation (KT) after a previous HSCT…2016 American Transplant Congress
Acute Rejection by Belatacept (Bela) Dosing Frequency: Results from a Phase II Study of Kidney Transplant Recipients.
Background: At 1 year post transplant in IM103-100 (NCT00035555), bela-treated patients had similar acute rejection (AR) rates and significantly improved renal function vs cyclosporine A…2016 American Transplant Congress
The Impact of Donor Procurement Characteristics in Contemporary Live Donor Pediatric Renal Transplantation Outcomes: An Analysis of 282 Cases.
Previous registry analyses have reported inferior graft survival rates when using laparoscopically procured organs and those with the greatest size mismatches between donor and recipient.…2016 American Transplant Congress
Cost-Effectiveness of Machine Perfusion Use After Long Cold Ischemic Time in a Kidney Transplantation Program.
Renal Transplantation Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
In Brazil the incidence of DGF is very high (60-70%) mainly due to an inadequate care of the donors and long cold ischemia time. This…2016 American Transplant Congress
Comparison of Efficacy of Different Regimens for Treating Recurrent IgA Nephropathy After Kidney Transplantation.
Background Recurrent IgA nephropathy is a common complication after kidney transplantation. How to treat recipients with recurrent IgA nephropathy is still controversial. There are two…2016 American Transplant Congress
Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.
Purpose: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality in renal transplant (RT) recipients. Post transplantation proteinuria…
- « Previous Page
- 1
- …
- 439
- 440
- 441
- 442
- 443
- …
- 531
- Next Page »
